Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V

EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)2023-08-092023-08-092023-07-18EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) 2023, 'Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V', EFSA Journal, vol. 21, no. 7, e08063. https://doi.org/10.2903/j.efsa.2023.80631831-4732PubMedCentral: PMC10352869ORCID: /0000-0002-9275-9713/work/140426717https://hdl.handle.net/2164/21454© 2023 European Food Safety Authority. EFSA Journal published by Wiley‐VCH GmbH on behalf of European Food Safety Authority.1092264engProtein hydrolysatecharacterisationinfant formulafollow-on formulanutritional safetysuitabilityclinical trialNutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.VJournal article10.2903/j.efsa.2023.8063217